Clinical Trial

A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to provide preliminary evidence for the efficacy of 12 weeks of vagal nerve stimulation (VNS) and nicotine replacement therapy (NRT) for increasing smoking abstinence rates.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-24
Trial Details
NCT Number NCT07487818
Lead Sponsor Mayo Clinic
Collaborators: National Cancer Institute (NCI)
Conditions Smoking Cessation
Enrollment 150 participants
Start Date 2026-04-15
Primary Completion 2027-01-15 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-23